Evidence map›Paper›PMID 38028688›Full record

ArticleHealth science reports2023

Concerning rates of laboratory-confirmed antifungal-resistant onychomycosis and tinea pedis: An online survey of podiatrists, United States.

Kaitlin Benedict, Jeremy A W Gold, Carolynn T Jones, Lisa A Tushla, Shari R Lipner, Warren S Joseph, Dyane E Tower, Boni Elewski, Peter G Pappas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaitlin BenedictMycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases Centers for Disease Control and Prevention Atlanta Georgia USA.ORCID 0000-0003-0458-2493
Jeremy A W GoldMycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases Centers for Disease Control and Prevention Atlanta Georgia USA.
Carolynn T JonesMycoses Study Group Education and Research Consortium Birmingham Alabama USA.
Lisa A TushlaTerranova Medica, LLC, Colorado Springs Colorado USA.
Shari R LipnerDepartment of Dermatology Weill Cornell Medicine New York New York USA.
Warren S JosephArizona College of Podiatric Medicine Midwestern University Glendale Arizona USA.
Dyane E TowerAmerican Podiatric Medical Association Bethesda Maryland USA.
Boni ElewskiDepartment of Dermatology University of Birmingham Birmingham Alabama USA.
Peter G PappasDepartment of Medicine, Division of Infectious Diseases University of Alabama at Birmingham Birmingham Alabama USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug resistance, fungalonychomycosispodiatrytinea pedisUnited States

Identifiers

PMID38028688
PMCPMC10667959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.